PLCE1 promotes myocardial ischemia–reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation

Abstract

Myocardial ischemia–reperfusion (I/R) injury is a major contributor to the morbidity and mortality associated with coronary artery disease. How to ensure the recovery of blood supply to ischemic myocardial tissue while avoiding or reducing I/R injury remains a critical problem in clinical practice. In the present study, we examined the function of phospholipase C ϵ-1 (PLCE1) by an H9c2 H/R (H/R, hypoxia–reoxygenation) model and a rat myocardial I/R injury model. The expression of PLCE1 and its effect on I/R injury-induced inflammatory response as well as its possible underlying mechanism were investigated. Our results have shown that PLCE1 was progressively increased along with the increase in hypoxia time in the H/R H9c2 and HL-1 cells. In myocardial I/R rats, PLCE1 presented a low expression level in the sham group, however, it was increased sharply in the I/R group. Overexpression of PLCE1 promoted the expression of IL-6, TNF-α, and IL-1α, and decreased the expression of IL-10. Knockdown of PLCE1 decreased the expression of IL-6, TNF-α, and IL-1α, and increased the expression of IL-10. Furthermore, overexpression of PLCE1 increased the phosphorylation of p38, ERK1/2, and nuclear factor-κ B (NF-κB) P65 while knockdown of PLCE1 inhibited their phosphorylation. In conclusion, the present study provided evidence that PLCE1 was up-regulated in H/R H9c2 cell and I/R rat. Overexpression of PLCE1 promoted the inflammatoion via activation of the NF-κB signaling pathway.

Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway

“…Cell culture. H9C2 cells were cultured in a hypoxic culture chamber (37˚C, 2.5% O 2 , 5% co 2 , 92.5% N 2 ) to establish a cellular model of MI (35). Cells in the control group were cultured in a normal culture chamber (37˚C, 5% CO 2 ).…”

Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway

“…Human ADSC-CM has a therapeutic effect on mouse ischemic stroke models mainly by reducing nerve cell apoptosis and increasing endothelial cell proliferation 24 . Bone marrow mesenchymal stem cell conditioned medium (BMSC-CM) reduced hypoxia-induced cardiomyocyte apoptosis 28 . Our previous study showed that ADSC-CM protected against I/R-induced injury in skin flaps 29 .…”

Directed Expression of Tracheal Antimicrobial Peptide as a Treatment for Bovine-Associated Staphylococcus Aureus-Induced Mastitis in Mice

“…For the transfection, the recombinant plasmid pBLG-TAP-EGFP-N1 was transiently transfected into mice using in Entranster- in vivo transfection reagent (Engreen Biosystem, Beijing, China) according to the manufacturer's instructions. Numerous studies have shown that the transfection agent causes limited inflammation in mice and rats ( 20 , 21 ). In brief, the mice in the prevention and treatment groups were injected with 150 μl of transfection master mix containing 18.75 μg of DNA, 37.5 μl of transfection reagent, 75 μl of 10% glucose solution, and 37.5 μl of double-distilled water, via caudal vein.…”